Adicet Bio, Inc. — Director's Dealing 2020

Sep 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2020-09-17

Reporting Person: DUBIN STEVE (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-17	Stock Option (Right to Buy)	$16.11	A	30000	Acquired	2030-09-16	Common Stock (30000)	Direct

Footnotes

F1: This option shall vest as follows: 1/36th of the shares shall vest on each of the next thirty-six (36) monthly anniversaries of the Vesting Commencement Date.